Axa’s Cambrex Corporation CBM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-13,800
Closed -$521K 1428
2018
Q4
$521K Buy
+13,800
New +$699K ﹤0.01% 1080
2015
Q4
Sell
-800
Closed -$32K 1534
2015
Q3
$32K Sell
800
-25,300
-97% -$1.18M ﹤0.01% 1382
2015
Q2
$1.15M Sell
26,100
-2,800
-10% -$116K ﹤0.01% 938
2015
Q1
$1.15M Sell
28,900
-41,700
-59% -$1.23M ﹤0.01% 917
2014
Q4
$1.53M Buy
70,600
+25,300
+56% +$537K 0.01% 862
2014
Q3
$847K Buy
+45,300
New +$973K ﹤0.01% 950
2014
Q2
Sell
-39,900
Closed -$753K 1461
2014
Q1
$753K Buy
39,900
+23,270
+140% +$449K ﹤0.01% 990
2013
Q4
$297K Hold
16,630
﹤0.01% 1156
2013
Q3
$220K Sell
16,630
-4,900
-23% -$69.3K ﹤0.01% 1130
2013
Q2
$301K Buy
+21,530
New +$282K ﹤0.01% 1059

Other funds holding CBM

Axa's CBM Position: Q1 2019 in Review

Axa sold out of Cambrex Corporation (CBM) in Q1 2019, closing a stake of 13,800 shares — an estimated $521K sold.

Axa first reported a position in CBM in Q2 2013 and held it in 10 quarters. The position peaked at $1.53M in Q4 2014. 211 funds tracked by Wall St. Rank hold CBM as of Q1 2019.

  • Axa reported no remaining Cambrex Corporation position as of Q1 2019 after selling out during the quarter.
  • Axa sold 13,800 Cambrex Corporation shares in Q1 2019, an estimated $521K.
  • Axa first reported a position in Cambrex Corporation in Q2 2013 and held it in 10 quarters.
  • Axa's Cambrex Corporation position peaked at $1.53M in Q4 2014.
  • 211 funds tracked by Wall St. Rank held Cambrex Corporation as of Q1 2019.

Based on Axa's 13F filing for Q1 2019, filed 14 May 2019.